Carisma Therapeutics (CARM)
OTHER OTC:CARM
Carisma Therapeutics (CARM) Ownership Overview
0.26% Mutual Funds
3.57% Other Institutional Investors
96.17% Public Companies and
Individual Investors
The ownership structure of Carisma Therapeutics (CARM) stock is a mix of institutional, retail, and individual investors. , and 96.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 08, 2025 | xxxxxxxxxxxxx | $14246 | |
Oct 03, 2025 | xxxxxxxxxxxxx | $122280 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 484,347 | Insider | 1.16% | 167,100 | |
| 83,036 | Institution | 0.20% | 3,072 | |
| 30,988 | Institution | 0.07% | 1,178 | |
| 15,224 | Institution | 0.04% | 563 | |
| 8,711 | Institution | 0.02% | 322 | |
| 1,005 | Institution | <0.01% | 37 | |
| 150 | Institution | <0.01% | 6 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 83,036 | Institution | 0.20% | 3,072 | |
| 15,224 | Institution | 0.04% | 563 | |
| 8,711 | Institution | 0.02% | 322 | |
| 1,005 | Institution | <0.01% | 37 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Carisma Therapeutics (CARM)?
Currently, no data Available
What percentage of Carisma Therapeutics (CARM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.57% of Carisma Therapeutics (CARM) stock is held by institutional investors.
What percentage of Carisma Therapeutics (CARM) stock is held by retail investors?
According to the latest TipRanks data, approximately 96.17% of Carisma Therapeutics (CARM) stock is held by retail investors.
Who owns the most shares of Carisma Therapeutics (CARM)?
Michael Klichinsky owns the most shares of Carisma Therapeutics (CARM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.